Analyst Ratings for Magenta Therapeutics (MGTA)

MGTA Rating Summary

MGTA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MGTA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $16.00 (+54.1%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/28/2021 Mizuho Securities Defei Yang New Coverage Buy
(N/A)
16.00
(N/A)
8.33
(10.38)
24.61% Details
10/14/2020 JPMorgan Jessica Fye New Coverage Overweight
(N/A)
N/A
(N/A)
7.67
(10.38)
35.33% Details
Like MGTA Ratings? Also take a look at AVRO, KLDO, BLUE, BEAM

MGTA Ratings News